Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Triple Negative Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05491694
What this trial is testing

To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer

Who this might be right for
Breast CancerTNBC - Triple-Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05675579
What this trial is testing

A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Ended earlyNCT06067061
What this trial is testing

"neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
Institut Curie 2
Testing effectiveness (Phase 2)Looking for participantsNCT05582499
What this trial is testing

Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy

Who this might be right for
Breast NeoplasmBreast CancerBreast Tumors+7 more
Fudan University 716
Testing effectiveness (Phase 2)UnknownNCT02685657
What this trial is testing

Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Russian Academy of Medical Sciences 164
Not applicableStudy completedNCT02521363
What this trial is testing

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04807192
What this trial is testing

CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer
Centre Hospitalier Universitaire Vaudois 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04335669
What this trial is testing

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Who this might be right for
Breast CancerTriple Negative Breast Neoplasms
Lund University Hospital 325
Testing effectiveness (Phase 2)Looking for participantsNCT07074106
What this trial is testing

TIL-Driven De-escalated Chemotherapy in Stage I-II TNBC

Who this might be right for
Breast Cancer
D'Or Institute for Research and Education 40
Not applicableUnknownNCT06448169
What this trial is testing

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerNeoadjuvant ImmunotherapySensitivity
Shandong University 200
Early research (Phase 1)Study completedNCT04081389
What this trial is testing

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+16 more
Roswell Park Cancer Institute 9
Not applicableLooking for participantsNCT05914961
What this trial is testing

Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
University Hospital Tuebingen 225
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06977542
What this trial is testing

Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer

Who this might be right for
TNBC, Triple Negative Breast Cancer
Fudan University 53
Not applicableNot Yet RecruitingNCT07551765
What this trial is testing

Diet-drive Gut Microbiome and Outcome in Patients With Early-stage Triple-negative Breast Cancer Undergoing Neoadjuvant Chemotherapy and Immunotherapy.

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early Setting
Barts & The London NHS Trust 300
Not applicableLooking for participantsNCT07211178
What this trial is testing

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Who this might be right for
Breast CancerTNBC - Triple-Negative Breast CancerHR Positive/HER-2 Negative Breast Cancer+2 more
Tempus AI 900
Not applicableLooking for participantsNCT05916755
What this trial is testing

Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform

Who this might be right for
Triple Negative Breast Cancer
Vall d'Hebron Institute of Oncology 100
Very early researchWithdrawnNCT05368506
What this trial is testing

ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Ovarian CarcinomaAdvanced Primary Peritoneal Carcinoma+8 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT07743190
What this trial is testing

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

Who this might be right for
Triple Negative Breast Cancer (TNBC)Elevated Tumor-Infiltrating Lymphocytes
Medical University of South Carolina 55
Testing effectiveness (Phase 2)Looking for participantsNCT07017673
What this trial is testing

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

Who this might be right for
TNBCTNBC - Triple-Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Cedars-Sinai Medical Center 34
Testing effectiveness (Phase 2)Looking for participantsNCT07016399
What this trial is testing

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Triple-Negative Breast Carcinoma
Vandana Abramson 51
Next Page